Approvals/CIMA-AEMPS/ABIRATERONA FRESENIUS KABI 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

ABIRATERONA FRESENIUS KABI 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Fresenius Kabi España, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 223ae760133b1dbb
Drug Cima Aemps Name: ABIRATERONA FRESENIUS KABI 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 86047
Holder Company Name: Fresenius Kabi España, S.A.U.
Marketing Company Name: Fresenius Kabi España, S.A.U.
Authorization Date: 2021-06-25
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 500 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Fresenius Kabi España, S.A.U.

ABIRATERONA ACETATO

500 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 25, 2021

Approval ID

223ae760133b1dbb

Type

Standard